Fredrik Wermeling

Fredrik Wermeling

Senior Forskare | Docent
Besöksadress: D2:01, Karolinska Universitetssjukhuset, 17177 Stockholm
Postadress: K2 Medicin, Solna, K2 Reuma Wermeling F, 171 77 Stockholm
Del av:

Om mig

  • Using experimental systems and patient material we study the immune system
    with a specific interest related to inflammation, autoimmune disease and
    cancer.
    A major part of the different projects in the lab involves using CRISPR-based
    custom screens as a discovery platform to understand complex biological
    processes and to identify novel drug targets.
    Currently several projects in the lab relates to our interest in signaling
    downstream of the IL-4 receptor (IL-4R). The basis for this interest was the
    unexpected finding that the expression of the IL-4R on myeloid cells is
    essential for the activity of a drug (IVIG) used to treat patients with
    autoimmune disease, and that this receptor is highly regulated during
    inflammation (Anthony et al, 2011, Nature and Wermeling et al, 2013, PNAS).
    The Wermeling Laboratory is located at the Center for Molecular Medicine
    (CMM), Karolinska University Hospital, Solna, Sweden. The group is part of
    the Devision of Rheumatology, Department of Medicine, Karolinska Institutet,
    Solna.
    Wenner-Gren fellow, 2010
    Ingvar Carlsson Award (SSF), 2013
    Senior Investigator Award from Swedish Cancer Foundation, 2022

Undervisning

  • More than 200h teaching in several KI programs, including Medical, Optometry,
    Biomedicine, and various master programs and PhD courses.

Artiklar

Alla övriga publikationer

Anställningar

  • Senior Forskare, Medicin, Solna, Karolinska Institutet, 2022-

Examina och utbildning

  • Docent, Immunologi, Karolinska Institutet, 2021
  • Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2010
  • Medicine Magisterexamen, Karolinska Institutet, 2009

Nyheter från KI

Kalenderhändelser från KI